MIG6 Mediates Adaptive and Acquired Resistance to ALK/ROS1 Fusion Kinase Inhibition through EGFR Bypass Signaling. Chen N, Tyler LC, Le AT, Welsh EA, et al. Mol Cancer Ther 2024;23:92-105.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chen N, Tyler LC, Le AT, Welsh EA, et al. MIG6 Mediates Adaptive and Acquired Resistance to ALK/ROS1 Fusion Kinase Inhibition through EGFR Bypass Signaling. Mol Cancer Ther 2024;23:92-105.
PMID: 37748191